ArticleAllergy2020
Handling of allergen immunotherapy in the COVID-19 pandemic: An ARIA-EAACI statement.
Open access · bronzeAbstract read
In one paragraph
Article in Allergy, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 63 papers, 1 of them a synthesis that pooled it.
0numbers the graph read from it
0cells of the map it votes in
63citing papers in PubMed, 1 pooled it
14.7field-weighted citation impact, top 1% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
63 citing papers in PubMed, 1 synthesis or guideline pooled it, 112 citations in OpenAlex.
- The immune system as a target for therapy of SARS-CoV-2: A systematic review of the current immunotherapies for COVID-19.Life sciences · 2020Pooled it
- The impact of public health emergencies on allergen immunotherapy practices: A cross-sectional study on COVID-19 and physicians' perspectives in China.Asia Pacific allergy · 2026Article
- Immunoglobulins: Mechanistic Approaches in Moderation of Various Inflammatory and Anti-inflammatory Pathways.Current pharmaceutical biotechnology · 2025Review
- Impact of COVID-19 on adverse reactions to subcutaneous specific immunotherapy in children:a retrospective cohort study.BMC infectious diseases · 2024Article
- Transition between subcutaneous and sublingual allergen immunotherapy: Recommendations of the Brazilian Association of Allergy and Immunology (ASBAI).The journal of allergy and clinical immunology. Global · 2024Review
- Safety and adverse reactions in subcutaneous allergen immunotherapy: a review.Acta bio-medica : Atenei Parmensis · 2023Review
- The relationship between sublingual immunotherapy for allergic rhinitis and the risk of symptoms in patients with COVID-19 infection.Human vaccines & immunotherapeutics · 2023Observational
- Aeroallergen immunotherapy associated with reduced risk of severe COVID-19 in 1095 allergic patients.The World Allergy Organization journal · 2023Article
- Deciphering Differential Behavior of Immune Responses as the Foundation for Precision Dosing in Allergen Immunotherapy.Journal of personalized medicine · 2023Review
- Clinical endpoints in allergen immunotherapy: State of the art 2022.Allergologie select · 2023Review
- Update about Oralair® as a treatment for grass pollen allergic rhinitis.Human vaccines & immunotherapeutics · 2022Review
- Allergic diseases and immunodeficiencies in children, lessons learnt from COVID-19 pandemic by 2022: A statement from the EAACI-section on pediatrics.Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology · 2022Article
- COVID-19 vaccination in patients receiving allergen immunotherapy (AIT) or biologicals-EAACI recommendations.Allergy · 2022Article
- SARS-CoV-2 Infection (COVID-19) and Rhinologic Manifestation: Narrative Review.Journal of personalized medicine · 2022Review
- Psychological impacts of coronavirus disease 2019 on people with asthma, allergic rhinitis, and food allergy.Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology · 2022Review
- Allergen immunotherapy during the COVID-19 pandemic-A survey of the German Society for Allergy and Clinical Immunology.Clinical and translational allergy · 2022Article
- Allergen-specific immunotherapy practices and course of coronavirus disease 2019 (COVID-19) in patients during COVID-19.Asia Pacific allergy · 2022Article
- Real-life report of allergen immunotherapy management during the COVID-19 outbreak in France and Spain.Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology · 2022Article
- 111 years of allergen-immunotherapy: A long and successful history of the only available disease-modifier in allergic diseases.Allergologie select · 2022Review
- Allergic patients during the COVID-19 pandemic-Clinical practical considerations: An European Academy of Allergy and Clinical Immunology survey.Clinical and translational allergy · 2022Article
3 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
45 authors at 20 institutions in 23 countries.
Ludger KlimekCenter for Rhinology and Allergology, Wiesbaden, Germany.
Marek JutelDepartment of Clinical Immunology, Wrocław Medical University, ALL-MED Medical Research Institute, Wrocław, Poland.
Cezmi AkdisSwiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Davos, Switzerland.ORCID https://orcid.org/0000-0001-8020-019X
Jean BousquetDepartment of Dermatology and Allergy, Berlin Institute of Health, Comprehensive Allergy Center, Berlin, Germany.
Mübeccel AkdisSwiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Davos, Switzerland.ORCID https://orcid.org/0000-0003-0554-9943
Claus BachertTransylvania University Brasov, Brasov, Romania.ORCID https://orcid.org/0000-0003-4742-1665
Ioana AgacheDepartment of Allergy and Immunology, Hospital Quirónsalud Bizkaia, Erandio, Spain.ORCID https://orcid.org/0000-0001-7994-364X
Ignacio AnsoteguiWoolcock Institute of Medical Research, University of Sydney, Woolcock Emphysema Centre, Sydney Local Health District, Glebe, NSW, Australia.
Anna BedbrookMACVIA-France, Montpellier, France.
Sinthia Bosnic-AnticevichPersonalized Medicine, Asthma and Allergy - Humanitas Clinical and Research Center IRCCS, Rozzano, MI, Italy.
Giorgio W CanonicaDepartment of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy.
Tomas ChivatoProAR - Nucleo de Excelencia em Asma, Federal University of Bahia, Bahia, Brazil.
Alvaro A CruzMedical Consulting Czarlewski, Levallois, and MASK-air, Montpellier, France.ORCID https://orcid.org/0000-0002-7403-3871
Wienia CzarlewskiDepartment of Medical Sciences and Public Health and Unit of Allergy and Clinical Immunology, University Hospital "Duilio Casula", University of Cagliari, Cagliari, Italy.
Stefano Del GiaccoDepartment of Respiratory Medicine, Wuhan Children's Hospital, Tongji Medical College, Huazhong, China.
Hui DuUniversity of Science and Technology, Wuhan, China.
Joao A FonsecaCenter for Research in Health Technologies and Information Systems- CINTESIS, Universidade do Porto, Porto, Portugal.
Yadong GaoUniversity of Science and Technology, Wuhan, China.
Tari HaahtelaHealth Information and Decision Sciences Department - CIDES, Faculdade de Medicina, Universidade do Porto, Porto, Portugal.ORCID https://orcid.org/0000-0003-4757-2156
Karin Hoffmann-SommergruberServicio de Alergia e Immunologia, Clinica Santa Isabel, Buenos Aires, Argentina.
Juan-Carlos IvancevichGARD Chairman, Geneva, Switzerland.
Nikolai KhaltaevDepartments of Immunology and Dermatology/Allergology, University Medical Center Utrecht, Utrecht, The Netherlands.
Edward F KnolDivision of Internal Medicine, Asthma and Allergy, Barlicki University Hospital, Medical University of Lodz, Lodz, Poland.
Piotr KunaCenter of Excellence in Asthma and Allergy, Médica Sur Clinical Foundation and Hospital, México City, Mexico.
Desiree Larenas-LinnemannInstitute of Environmental Medicine, Karolinska Institutet and Sachs' Children's Hospital, Stockholm, Sweden.
Erik MelenRhinology Unit & Smell Clinic, ENT Department, Hospital Clínic, Barcelona, Spain.
Joaquim MullolClinical & Experimental Respiratory Immunoallergy, IDIBAPS, CIBERES, University of Barcelona, Barcelona, Spain.
Robert NaclerioNational Hospital Organization, Tokyo National Hospital, Tokyo, Japan.
Ken OhtaDepartment of Otorhinolaryngology, Chiba University Hospital, Chiba, Japan.ORCID https://orcid.org/0000-0001-9734-4579
Yoshitaka OkamotoDepartments of Medicine and Microbiology, APC Microbiome Ireland, University College Cork, Cork, Ireland.
Liam O'MahonyDivision of Infection, Immunity & Respiratory Medicine, Royal Manchester Children's Hospital,, University of Manchester, Manchester, UK.
Gabrielle L OnoratoMACVIA-France, Montpellier, France.
Nikos G PapadopoulosDepartment of Pediatrics, Nippon Medical School, Tokyo, Japan.
Ruby PawankarDepartment of Otorhinolaryngology, Head and Neck Surgery, Section of Rhinology and Allergy, University Hospital Marburg, Phillipps-Universität Marburg, Marburg, Germany.
Oliver PfaarDepartment of Otorhinolaryngology, Head and Neck Surgery, Section of Rhinology and Allergy, University Hospital Marburg, Phillipps-Universität Marburg, Germany.ORCID https://orcid.org/0000-0003-4374-9639
Boleslaw SamolinskiDepartment of Prevention of Environmental Hazards and Allergology, Medical University of Warsaw, Warsaw, Poland.
Jurgen SchwarzeCentre for Inflammation Research, Child Life and Health, The University of Edinburgh, Edinburgh, UK.
Sanna Toppila-SalmiAllergy Unit, Instituto CUF Porto e Hospital CUF Porto, Porto, Portugal.ORCID https://orcid.org/0000-0003-0890-6686
Mohamed H ShamjiUnit of Geriatric Immunoallergology, University of Bari Medical School, Bari, Italy.ORCID https://orcid.org/0000-0003-3425-3463
Maria Teresa VenturaVilnius University Faculty of Medicine, Institute of Clinical Medicine & Institute of Health Sciences, Vilnius, Lithuania.
Arunas ValiulisDepartment of Pulmonology, Celal Bayar University, Manisa, Turkey.
Arzu YorganciogluCharité - Universitätsmedizin Berlin, Berlin, Germany.
Paolo MatricardiImmunomodulation and Tolerance Group, Allergy and Clinical Immunology, Inflammation, Repair and Development, National Heart and Lung Institute, Imperial College London, London, UK.ORCID https://orcid.org/0000-0002-2145-3776
Torsten ZuberbierAsthma UK Centre in Allergic Mechanisms of Asthma, London, UK.ORCID https://orcid.org/0000-0002-1466-8875
ARIA-MASK Study Group
Helsinki University Hospital · FIHumboldt-Universität zu Berlin · DEUniversity of Zurich · CHAsthma UK · GBBoston Children's Hospital · USCentre for Inflammation Research · GBCharité - Universitätsmedizin Berlin · DEChiba University Hospital · JPEuropean Union of Medical Specialists · BEGhent University Hospital · BEGlobal Antibiotic Research & Development Partnership · CHHospital Clínic de Barcelona · ESHospital Médica Sur · MXHospital Quirónsalud Barcelona · ESHumanitas University · ITJohns Hopkins University · USLEK Consulting (United States) · USManisa Celal Bayar University · TRMedical University of Lodz · PLMedical University of Vienna · AT
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
AllergistsAsthmaBetacoronavirusCD8-Positive T-LymphocytesCoronavirus InfectionsCOVID-19EosinophilsHumansImmunoglobulin EImmunoglobulin MInfection ControlPandemicsPneumonia, ViralRhinitis, AllergicSARS-CoV-2Sublingual ImmunotherapyImmunoglobulin EImmunoglobulin Mallergy treatmentimmunotherapy clinicalimmunotherapy vaccines and mechanisms
Identifiers
What Socratic holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.